Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - February, 2006
43 articles
- Ex-Generic Drug Maker Files Chapter 11 Plan
- Injunction Clears Early Threat To TAP's Lupron Depot
- Judge Reverses $51M Verdict In Medical Device Suit
- SEC Bypasses Fair Fund In Favor Of Claims Administrator
- Group Moves To Thwart Tamiflu Patent In India
- Federal Circuit Deals Blow To Glaxo In Patent Fight
- Monsanto In $200M Settlement Over Hormone Patents
- Early Approval For Flonase Generic Puts Glaxo In A Bind
- Lerner David Gears Up For High-Stakes Patent Case
- $4.6B Biovail Suit Attacks Shorting By Hedge Funds
- Third Wave Drops HCV Suit Against Chiron, Bayer
- Generics Makers Denied In Diabetes Drug Patent Suit
- Fiat Subpoenaed As SEC Widens Oil-For-Food Probe
- Medinol Claims Old Partner Infringes Stent Patents
- AstraZeneca Slapped with Antitrust Lawsuit Over Toprol
- MedImmune-Genentech Battle Moves To High Court
- SEC Subpoenas Novo Nordisk In Oil-For-Food Probe
- Teva Shoots Back With Suit Against Pfizer
- Medtronic Targeted In New Lawsuit By Scientist
- Smallpox Drug Makers Fight Patent War On Two Fronts
- After Years of Fighting, Gillette and Schick Call Truce
- AstraZeneca Appeals Toprol-XL Patent Invalidity
- Jones Day Nabs IP Bigwig With Eye On China
- Federal Circuit Axes Drug Patent For Inequitable Conduct
- HCA Insiders May Be In Hot Water Again
- Judge Upholds FDA Rule On Market Exclusivity
- Applera, Bio-Rad End Patent Battle Over PCR
- Teva Copied Zithromax Update: Pfizer Lawsuit
- IP Boutique Sughrue Mion Sets Its Sights On Asia
- Bristol-Myers Set To Pay Shareholders $185M
- Pfizer Takes Action Against Generics At FDA
- Endo Presses On With Generic OxyContin Despite Risks
- Chiron Off The Hook For Securities Violations
- Fish & Richardson Ranked #1 In Patent Litigation Survey
- McDermott Hooks Arnold & Porter's IP Head
- Federal Circuit Reverses Priority In Claritin Battle
- Medisys, Roche Settle Patent Row Over Diabetics Device
- Drug Co. Slapped With Securities Fraud Class Action
- IP Boutique Fitzpatrick Cella Embraces Meritocracy
- Medtronic Sues Biomet Over Spinal Fusion Patents
- Cephalon, Barr End Clash Over Provigil
- E.U. Trumps FDA In Approval Of Biologics
- OxyContin Given New Lease On Life By Federal Circuit